BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7898011)

  • 1. [Immunological aspects of wound healing in patients with diabetes mellitus].
    Kim AIu; Morozov IuI; Kirdeĭ EG
    Klin Med (Mosk); 1994; 72(6):48-50. PubMed ID: 7898011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-lymphocyte subsets and their cytotoxic capacity in patients with type I and type II diabetes mellitus.
    Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
    Allergol Immunopathol (Madr); 1986; 14(5):399-405. PubMed ID: 3492131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of xenotransplantation of pancreatic islet cells on the immune status of patients with diabetes mellitus].
    Morozov IuI; Kirdeĭ EG; Kim AIu
    Klin Med (Mosk); 1995; 73(2):32-4. PubMed ID: 7609413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity in diabetes mellitus.
    Narang NK; Gupta RC; Singh N
    J Assoc Physicians India; 1989 Sep; 37(9):614. PubMed ID: 2632568
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoclinical correlation in diabetes mellitus. A preliminary report on the lectin-agglutination test.
    Mukherjee N; Biswas TK; Mitra S; Gupta N; Sarkar M
    J Assoc Physicians India; 1991 Feb; 39(2):172-4. PubMed ID: 1885479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological aspects of diabetic angiopathies pathogenesis].
    Galenok VA; Zhuk EA
    Ter Arkh; 1998; 70(10):5-10. PubMed ID: 9864794
    [No Abstract]   [Full Text] [Related]  

  • 7. Similar alterations of lymphocyte subpopulations in type I and type II diabetes.
    Spooren PF; Vermes I; Soons JW
    Neth J Med; 1993 Jun; 42(5-6):163-7. PubMed ID: 8377873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active rosette forming T-lymphocytes in diabetes mellitus.
    Uriarte A; Ventura R; Gabrera E; Perich P
    Exp Clin Endocrinol; 1987 Aug; 89(3):307-11. PubMed ID: 3499332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Wound healing process differences in type I and type II diabetes mellitus].
    Kim AIu; Gol'dberg OA; Morozov IuI
    Khirurgiia (Mosk); 1998; (5):46-7. PubMed ID: 9642961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disorders of cellular immunity in newly detected diabetes mellitus type 1].
    Skuratowicz-Kubica A; Mysliwska J; Bakowska A; Lass P; Horoszek-Maziarz S
    Pol Tyg Lek; 1988 Mar; 43(10):325-8. PubMed ID: 3261421
    [No Abstract]   [Full Text] [Related]  

  • 11. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides.
    Abulafia-Lapid R; Elias D; Raz I; Keren-Zur Y; Atlan H; Cohen IR
    J Autoimmun; 1999 Mar; 12(2):121-9. PubMed ID: 10047432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological changes in diabetes mellitus. Study of lymphocyte populations].
    Resegotti L; Palestro G; Pistone MA; Diana A; Dolci C; Leonardo E; Testa D
    Arch Sci Med (Torino); 1979; 136(2):265-74. PubMed ID: 316318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of T-lymphocyte subpopulations in juvenile-onset diabetics.
    Müller R; Kolb H; Kuschak D; Jörgens V; Gries FA
    Clin Exp Immunol; 1980 Jan; 39(1):130-5. PubMed ID: 6966986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [State of the T and B immunity systems in diabetes mellitus in children].
    Martynova MI; Smirnov VV; Semenkov VF; Akimova ON
    Pediatriia; 1980 Jun; (6):36-8. PubMed ID: 6967590
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heterogeneity of diabetes mellitus].
    Asfandiiarova NS; Kolcheva NG; Shatrova IV
    Ter Arkh; 1999; 71(12):49-52. PubMed ID: 10647203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte populations and cell-mediated immunity in juvenile insulin-dependent diabetes mellitus.
    Kadranka-Lovrencić M; Rabatić S; Sabioncello A; Mazuran R; Oberiter V; Dekaris D
    Acta Med Iugosl; 1981; 35(1):3-9. PubMed ID: 6973913
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemolytic plaque cells (plaque forming cells) in patients with type I and type II diabetes mellitus].
    Goldoni V; Marotti T; Vrbanec D; Cabrijan T; Zjacić-Rotkvić V; Pavelić K; Sekso M
    Acta Med Iugosl; 1986; 40(3):201-6. PubMed ID: 3535390
    [No Abstract]   [Full Text] [Related]  

  • 18. [The characteristics of T-lymphocyte differentiation in type-1 diabetes mellitus].
    Zhuk EA; Galenok VA
    Ter Arkh; 1995; 67(10):12-5. PubMed ID: 8779094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
    Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular immunity in patients with diabetes mellitus complicated by diabetic retinopathies].
    Danilova AI; Dekhtiareva OS
    Probl Endokrinol (Mosk); 1984; 30(5):29-34. PubMed ID: 6334294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.